Association of Beta-2 Microglobulin with Stroke and All-Cause Mortality in Adults Aged ≥40 in U.S.: NHANES III
Open Access
- 2 February 2023
- journal article
- research article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (2) , 43
Abstract
Background: Stroke is the predominant cause of death worldwide. We aimed to investigate the association of serum beta-2 microglobulin (β2M) concentrations with risk of stroke and all-cause mortalities in a cohort study. Methods: Overall, 4914 U.S. adults (mean age = 63.0 years, 44.3% male) were recruited from the National Health and Nutrition Examination Survey (NHANES Ⅲ). During a median follow-up of 19.4 years, 254 stroke deaths and 3415 all-cause deaths were identified by the National Center for Health Statistics. The associations of β2M with stroke and all-cause mortalities were investigated by using weighted Cox proportional hazard regression models. Results: β2M was positively associated with stroke and all-cause mortality in unadjusted models and multivariable-adjusted models. The multivariable HR (95% CI) for stroke mortality in Q5 VS Q1 of serum β2M concentrations was 3.45 (1.33–8.91; p for trend = 0.001) and that for all-cause mortality was 3.95 (3.05–5.12; p for trend < 0.001). In subgroup analyses, the association of β2M and stroke mortality did not vary by different levels of sociodemographic and general stroke risk factors (p interaction > 0.05). In addition, the magnitude of positive association between β2M with all-cause mortality did vary by age, ratio of family income to poverty, smoking status, and history of hypertensive (p interaction < 0.05). Conclusions: Our findings suggest that support that β2M may be a marker of stroke and all-cause mortality, which provides a new perspective for the study of cerebrovascular health and long-term survival in the future.Keywords
Funding Information
- National Social Science Fund of China (15BSH057)
This publication has 48 references indexed in Scilit:
- Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 StudyNeuroepidemiology, 2015
- Cardiac and Kidney Markers for Cardiovascular Prediction in Individuals With Chronic Kidney DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Global Stroke StatisticsInternational Journal of Stroke, 2013
- Serum β-2 microglobulin predicts mortality in people with diabetesEuropean Journal of Endocrinology, 2013
- Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patientsKidney International, 2012
- Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled studyHeart and Vessels, 2012
- Novel Markers of Kidney Function as Predictors of ESRD, Cardiovascular Disease, and Mortality in the General PopulationAmerican Journal of Kidney Diseases, 2012
- Socioeconomic Status and StrokeStroke, 2012
- Beta 2 Microglobulin and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid AtherosclerosisStroke, 2011
- The Impact of β2-Microglobulin Clearance on the Risk Factors of Cardiovascular Disease in Hemodialysis PatientsASAIO Journal, 2010